Samenvatting
Candida albicans is a widespread commensal fungus with substantial pathogenic potential and steadily increasing resistance to current antifungal drugs. It is known to be resistant to cycloheximide (CHX) that binds to the E–transfer RNA binding site of the ribosome. Because of lack of structural information, it is neither possible to understand the nature of the resistance nor to develop novel inhibitors. To overcome this issue, we determined the structure of the vacant C. albicans 80S ribosome at 2.3 angstroms and its complexes with bound inhibitors at resolutions better than 2.9 angstroms using cryo–electron microscopy. Our structures reveal how a change in a conserved amino acid in ribosomal protein eL42 explains CHX resistance in C. albicans and forms a basis for further antifungal drug development.
Originele taal-2 | English |
---|---|
Artikelnummer | eabn1062 |
Aantal pagina's | 7 |
Tijdschrift | Science Advances |
Volume | 8 |
Nummer van het tijdschrift | 21 |
DOI's | |
Status | Published - 25-mei-2022 |
Vingerafdruk
Duik in de onderzoeksthema's van 'E-site drug specificity of the human pathogen Candida albicans ribosome'. Samen vormen ze een unieke vingerafdruk.Pers/Media
-
GN/ New CRISPR-combo boosts genome editing power in plants
01/06/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
Cryogenic electron microscopy reveals drug targets against common fungus
28/05/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular
-
La microscopie électronique cryogénique révèle ta drogue
26/05/2022
1 item van Media-aandacht
Pers / media: Expert Comment › Popular